Finance

Lists
Why is 532834 up ६.६३%?
Dive Deeper
532834:BOM
Camlin Fine Sciences Ltd
₹ ९६.००
+६.६३%
(+५.९७) 1D
अक्टोबर १६, १५:३०:०० GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 532834...
Open
₹ ८९.५२
High
₹ ९८.००
Low
₹ ८९.४३
Mkt. cap
१८.३३ अरब
Avg. vol.
४५.४८ हजार
Volume
२.०५ लाख
P/E ratio
३३८.८६
52-wk high
₹ २०४.३५
52-wk low
₹ ८८.२७
EPS
₹ ०.२८
Shares outstanding
१२.१३ करोड
No. of employees
६७४
Open
₹ ८९.५२
High
₹ ९८.००
Low
₹ ८९.४३
Mkt. cap
१८.३३ अरब
Avg. vol.
४५.४८ हजार
Volume
२.०५ लाख
P/E ratio
३३८.८६
52-wk high
₹ २०४.३५
52-wk low
₹ ८८.२७
EPS
₹ ०.२८
Shares outstanding
१२.१३ करोड
No. of employees
६७४
News stories
From web sources and news partners
Profile
Camlin Fine Sciences originated as part of the Camlin group, an Indian manufacturer of stationery and art materials. The company subsequently expanded into the specialty chemicals sector, focusing on antioxidant ingredients and related chemical products. During the 2000s and 2010s, the company expanded its international operations through acquisitions and investments in overseas manufacturing facilities. These activities increased the company's presence in Europe and Latin America and broadened its product portfolio. In 2015, Camlin Fine Sciences acquired a controlling interest in Dresen Química, a Brazilian manufacturer of food preservation and shelf-life extension products. The acquisition expanded the company's operations in South America. The company later expanded its activities in aroma chemicals and vanillin production through investments in manufacturing facilities and related businesses. Company manufactures chemicals to improve the shelf life of food and other products like aromatic compounds, and performance chemicals. CFS has emerged as the largest producer of food antioxidants such as tert-Butylhydroquinone and Butylated hydroxyanisole. Wikipedia
About Camlin Fine Sciences Ltd
CEO-
Employees६७४
Founded१९३१
Headquarters-
SectorSpeciality chemicals
Last report
२०२६ अगस्ट ११
Fiscal period
Q1 2027
-₹ ०.९९ / ₹ ०.१२
-९२१.१७%miss
Revenue / Est. (INR)
५.२० अरब / ५.११ अरब
+१.६६%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
४.६० अरब
४.५७ अरब
३.८३ अरब
५.२० अरब
Cost of goods sold
२.४७ अरब
२.४८ अरब
२.२४ अरब
३.०६ अरब
Cost of revenue
२.४७ अरब
२.४८ अरब
२.२४ अरब
३.०६ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
६०.२९ करोड
६३.७६ करोड
८८.७० करोड
७३.४३ करोड
Operating expense
१.९९ अरब
२.०४ अरब
१.५२ अरब
२.१६ अरब
Total operating expenses
४.४५ अरब
४.५२ अरब
३.७६ अरब
५.२१ अरब
Operating income
१४.५९ करोड
५.३० करोड
६.५५ करोड
-१.५१ करोड
Other non operating income
१.७२ करोड
२.९४ करोड
-९.४८ करोड
१.३४ करोड
EBT including unusual items
-९.२३ लाख
-२७.८५ करोड
२२.४७ लाख
-३२.२६ करोड
EBT excluding unusual items
-९.२३ लाख
-१०.३४ करोड
९.४५ करोड
-२१.१५ करोड
Income tax expense
५.९१ करोड
४.५२ लाख
-६.४० करोड
-४६.३० लाख
Effective tax rate
-६,४०५.३१%
-०.१६%
-२,८४९.३१%
१.४४%
Other operating expenses
१.१९ अरब
१.२३ अरब
४४.९९ करोड
१.२३ अरब
Net income
-१४.३८ करोड
-३६.२३ करोड
८८.२० करोड
-३१.७१ करोड
Net profit margin
-३.१३%
-७.९२%
२३.०५%
-६.१०%
Earnings per share
-०.२९
-०.९४
०.७६
-०.९९
Interest and investment income
-
-
७.९६ करोड
-
Interest expense
-१५.२१ करोड
-१८.३३ करोड
-७.६८ करोड
-१६.२८ करोड
Net interest expenses
-१५.२१ करोड
-१८.३३ करोड
२८.५७ लाख
-१६.२८ करोड
Depreciation and amortization charges
१८.८३ करोड
१६.७३ करोड
१८.४४ करोड
१९.१६ करोड
EBITDA
३२.४६ करोड
२०.३२ करोड
१९.९१ करोड
११.८५ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google एपहरू